FMP
Notre Dame Intermédica Participações S.A.
GNDI3.SA
SAO
Inactive Equity
Notre Dame Intermédica Participações S.A. provides preventive medicine programs in Brazil. The company offers preventive medicine programs for pregnant women and the elderly, as well as for patients with chronic diseases, such as hypertension, diabetes, obesity, back problems, asthma, bronchitis, and heart diseases; and oncology programs. It also provides health, dental, and occupational health plans. The company was formerly known as BCBH Participações S.A. and changed its name to Notre Dame Intermédica Participações S.A. on April 25, 2017. Notre Dame Intermédica Participações S.A. was founded in 1968 and is headquartered in São Paulo, Brazil.
66.95 BRL
66.95 (100%)
DuPont Analysis
The DuPont analysis, pioneered by the DuPont Corporation, offers a structured approach to assessing fundamental performance. It involves breaking down the return on equity (ROE) into various components, aiding investors in comprehending the factors influencing a company's returns.
ROE = Net Income / Average Total Equity
ROE = (Net Income / Sales) * (Revenue / Average Total Assets) * (Average Total Assets / Average Total Equity)
The company's tax burden is (Net income ÷ Pretax profit). This is the proportion of the company's profits retained after paying income taxes. [NI/EBT] The company's interest burden is (Pretax income ÷ EBIT). This will be 1.00 for a firm with no debt or financial leverage. [EBT/EBIT] The company's operating income margin or return on sales (ROS) is (EBIT ÷ Revenue). This is the operating income per dollar of sales. [EBIT/Revenue] The company's asset turnover (ATO) is (Revenue ÷ Average Total Assets). The company's equity multiplier is (Average Total Assets ÷ Average Total Equity). This is a measure of financial leverage. Profitability (measured by profit margin) Asset efficiency (measured by asset turnover) Financial leverage (measured by equity multiplier)
